John Pinion
Vermögen: 3 Mio $ am 31.05.2026
Vermögen: 3 Mio $ am 31.05.2026
John Richard Pinion currently works at Aroa Biosurgery Ltd., as Independent Non-Executive Director from 2015, Aroa Biosurgery, Inc., as Director, and Ultragenyx Pharmaceutical, Inc., as Chief Quality Operations Officer & Executive VP from 2017.
Mr. Pinion also formerly worked at Baxter BioScience Corp., as Vice President-Quality, Genentech, Inc., as Senior VP, Global Head-Quality & Compliance from 2008 to 2009, and Roche Holding AG, as Senior VP, Global Head-Quality & Compliance from 2009 to 2015.
Mr. Pinion received his undergraduate degree in 1988 from West Virginia University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 16.04.2026 | 133’142 ( 0.14% ) | 3 Mio $ | 31.05.2026 | |
AROA BIOSURGERY LTD 0.14% | 31.10.2025 | 472’500 ( 0.14% ) | 236 274 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| AROA BIOSURGERY LIMITED | Direktor/Vorstandsmitglied | 01.02.2015 |
| ULTRAGENYX PHARMACEUTICAL INC. | Corporate Officer/Principal | 01.07.2015 |
| Unternehmen | Position | Ende |
|---|---|---|
| ROCHE HOLDING AG | Compliance Officer | 01.07.2015 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Compliance Officer | 01.01.2009 |
Baxter BioScience Corp.
Baxter BioScience Corp. BiotechnologyHealth Technology Provides biopharmaceutical and vaccines services | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Roche Holding AG
Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
Ultragenyx Pharmaceutical, Inc.
Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases | Health Technology |
West Virginia University
West Virginia University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baxter BioScience Corp.
Baxter BioScience Corp. BiotechnologyHealth Technology Provides biopharmaceutical and vaccines services | Health Technology |
Aroa Biosurgery Ltd.
Aroa Biosurgery Ltd. Medical SpecialtiesHealth Technology Develops medical devices for soft tissue regeneration and cellular scaffolding | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen